Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma

Jin‐Hua Liang(Broad Institute), Wei Xu(Jiangsu Province Hospital), Hao-Rui Shen(Nanjing Medical University), Rui Gao(Sichuan University), Yifan Wu(Jiangsu Province Hospital), Kai‐Xin Du(Jiangsu Province Hospital), Junheng Liang(Jiangsu Province Hospital), Wei Hua(Sichuan University), Li Wang(Beihang University), Yue Li(Southwest Petroleum University), Jianyong Li(Jiangsu Province Hospital), Liuqing Zhu, Xinyu Zhang(Guangdong Academy of Medical Sciences), Jia‐Zhu Wu(Augusta University Health), Yang Shao, Tong‐Yao Xing(Jiangsu Province Hospital), Hua Yin(Yunnan University of Traditional Chinese Medicine), Chunyu Shang(Southwest University), Chenxuan Wang(University of Guelph)
Leukemia
May 15, 2024
10.1038/s41375-024-02279-7
Cited by 15

Related Papers

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study
|Critical Care|2020|450
Interfacial Water Structure Associated with Phospholipid Membranes Studied by Phase-Sensitive Vibrational Sum Frequency Generation Spectroscopy
|Journal of the American Chemical Society|2010|397
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis
|Critical Care|2020|389